In Partnership with ALCSI
Lung Cancer Screening
Risk Assessment
Takes under 2 minutes  ·  100% confidential  ·  Bilingual
1 in 16
Americans will be diagnosed with lung cancer in their lifetime
80%
5-year survival rate when lung cancer is caught at Stage I
77%
of lung cancers are diagnosed at a late, less treatable stage
more deaths than breast and colon cancer combined annually
Why take this screening today?
Early detection saves lives. LDCT screening reduces lung cancer mortality by up to 20% in high-risk individuals (NLST trial, NEJM 2011).
Clinically validated. Uses the Bach and PLCOm2012 models — the two most widely validated lung cancer risk tools used in hospitals worldwide.
Quick & non-invasive. No blood draw, no appointment needed. Answer a few questions and receive your personalised risk result instantly.
Support research. Your de-identified responses contribute to the ALCSI national lung cancer screening database.
💡 The U.S. Preventive Services Task Force recommends annual lung cancer screening for adults aged 50–80 who have a 20+ pack-year smoking history and currently smoke or quit within the past 15 years.

Educational purposes only · Solo fines educativos
American Lung Cancer Screen Initiative (ALCSI)